Overview

Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-04958242 In Healthy Volunteers

Status:
Completed

Trial end date:
2014-11-13

Target enrollment:

Participant gender:

Summary

This study aims to assess the safety, tolerability, and pharmacokinetics of PF-04958242 at a number of single ascending doses in healthy volunteers

Phase:

Phase 1

Details

Lead Sponsor:

Biogen
Pfizer